Loading

Annals of Neurodegenerative Disorders

Comparative Evaluation of the Ameliorating Effects of Some Natural Products as Neurotherapeutic Interventions for a Neurodegenerative Disorder in Status Epilepticus Model

Research Article | Open Access | Volume 8 | Issue 1

  • 1. Department of Medical Surgical Nursing, King Saud University, Saudi Arabia
  • 2. Department of Medical Surgical Nursing, King Saud University, Saudi Arabia
  • 3. Department of Medical Surgical Nursing, King Saud University, Saudi Arabia
  • 4. Department of Medical Surgical Nursing, King Saud University, Saudi Arabia
+ Show More - Show Less
Corresponding Authors
Mohammad Ahmad, Department of Medical Surgical Nursing, King Saud University, Riyadh, Saudi Arabia
Abstract

Background: The lithium-pilocarpine (Li-Pc) model of status epilepticus (SE) is the most convenient and is frequently used for pathophysiological and management strategies in search of new, safe, and effective therapeutic agents including natural remedies for SE. Oral administration of cinnamon (CIN), Nigella sativa (NS), and curcumin (CUR) can reduce neuroinflammation which is a common feature of neurodegenerative disorders. Although many studies on CUR and NS effects on SE have been undertaken, to our best knowledge no study has been conducted on studying the effect of CIN on SE.

Purpose: The present study explores the neuroprotective effects of natural food products CUR, NS, and CIN on Li-Pc-induced SE in rats. This study may help to understand the neurotherapeutic effects of these natural food products on cognitive dysfunctions and brain oxidative stress which have a correlative perspective with SE.

Methods: SE was induced in experimental rats using the lithium–pilocarpine model. Besides control groups, the animals were also grouped as treatment groups which received CIN, NS, and CUR pre-treatment before induction of SE. Besides the severity of the seizures, and cognitive dysfunctions, the oxidative stress parameters were also estimated in the fore-brain tissue of all groups of animals.

Results: Treatment with CIN, NS, and CUR significantly lessened the frequency and severity of epileptic seizures in a dose-dependent manner. The cognitive dysfunctions and the oxidative stress indices (enzymatic and non-enzymatic) were ameliorated significantly and dose-dependently by these natural food products pre-treatments in the order NS<CIN<CUR in all parameters.

Conclusion: Possible therapeutic applications of CIN, NS, and CUR as antiepileptics and as antioxidants for the treatment of SE in the order NS<CIN<CUR, have great potential and warrant further studies. Most importantly, involving such natural food products for neurotherapeutic applications bears great significance from a healthcare point of view for neurodegenerative disorders.

KEYWORDS
  • Natural food products
  • Status epilepticus
  • Neuroprotection
  • Neurotherapeutics
  • Curcumin
  • Nigella sativa
  • Cinnamon
CITATION

Ahmad M, Alharbi H, Alshehry AS, Alsadoun A (2024) Comparative Evaluation of the Ameliorating Effects of Some Natural Products as Neu- rotherapeutic Interventions for a Neurodegenerative Disorder in Status Epilepticus Model. Ann Neurodegener Dis 8(1): 1035.

INTRODUCTION

The animal models serve a great purpose because we do not have to expose human subjects to health risks for observing the course of a disease and to study the effects of interventions by natural or synthetic compounds through reliable, ethical, responsible, economical, and safe preclinical assays in early stages of screening processes in search of newer natural food products as neurotherapeutic compounds for treating various diseases of the nervous system.

Status epilepticus (SE) is a neurodegenerative condition causing neuronal injuries in the brain [1], due to neurochemical imbalances in affected brain regions [2]. Ample evidences exist for the association of such chemical imbalances with excessive generation of free radicals suggesting vulnerability of the brain tissue to the oxidative stress [3,4]. Lithium (Li) Pilocarpine (PC) induced SE in rodent models has provided information regarding oxidative stress-related epileptic activity [5-7]. Furthermore, oxidative stress has also been related to cognitive impairment [7-9]. SE affects brain cell survival and function by targeting multiple adversities in the neuronal microenvironment such as inflammation, oxidative stress, mitochondrial alterations, calcium excitotoxicity, and bioenergetic challenges. The Li–Pc model of SE reproduces most clinical, temporal, and neuropathological features of SE [2,10]. Although the anticonvulsant effect of several agents having antioxidant properties has been demonstrated in various studies [2,11,12], the unsatisfactory outcomes of available SE pharmacotherapy necessitate the search for alternative natural resources that can target the various underlying mechanisms of SE pathology and reduce disease occurrence and/or progression. Among the natural resources, many studies on Nigella sativa (NS) and curcumin (CUR) effects on SE have been undertaken [7,13- 15], but no study as such has been conducted on studying the effect of cinnamon (CIN) on SE for having antiepileptic potential in experimentally induced SE.

Many recent studies have reported protective effects of Cur against oxidative damage and antioxidant and anticonvulsant properties exerting powerful oxygen free radical scavenging effects, anti-inflammatory, anticarcinogenic, antitumoral, antiviral, antifungal, antiparasitic, antimutagen, anti-infectious and antihepatotoxic compound [5,6,8,9,16-21].

Recent studies have shown significant potential of pharmacological, prophylactic, or therapeutic use of Nigella sativa (habba sauda) seed extract (NS) in many beneficial activities in the body including neuroprotection from neurodegenerative diseases and antioxidant properties [22-30]. A literature review has also shown that NS and its components can be considered as promising agents in the treatment of nervous system disorders [14].

Although CIN is widely used as a spice and as a traditional medicine for blood sugar control [31], anti-oxidant [32], anti- inflammatory [33], antimicrobial activities [34], an inhibitory effect on Tau aggregation related to AD [35], anti-cancer [36,37], cardiovascular disease [38], wound healing [39], inflammatory syndromes, cholesterol levels, immunomodulatory diseases [40,41], neuroprotective/neurodegenerative purposes [35,42,43], to the authors best knowledge, no studies have been undertaken to see effects of CIN on epilepsy or SE as anticonvulsant.

In the light of the above, the present study explores the neuroprotective effects of natural food products CUR, NS and CIN on Li-Pc induced SE in rats. This study may encourage to understand cognitive dysfunctions and brain oxidative stress which have a correlative perspective with SE. Furthermore, such research works can help in to understand indirectly the importance of screening natural food products that are beneficial as neurotherapeutic agents in ameliorating the convulsions, brain oxidative stress and cognitive dysfunctions in SE.

MATERIALS AND METHODS

Experimental Animals

Adult male Sprague Dawley rats (weighing 200-250g, 2 months old) were used in the present study. The animals were taken care of under controlled conditions at 22 ± 1°C, humidity at 50-60% with 12 hours light-dark diurnal cycle with free access to food and water except during experimental handlings. All animal handling procedures and study protocols were followed as according to the approved directions from the Research and Ethics Committee of King Saud University, Riyadh, Saudi Arabia for executing the experiments.

Induction of Status Epilepticus (SE) and Treatment Groups

Animals were randomly assigned into twelve groups. Groups 1, 2, 3, 4, and 5 served as controls receiving saline, Li (3mEq/ml/ kg, i.p.), Pc (20mg/ml/kg, s.c.), 50 % dimethyl sulfoxide (DMSO) and 0.5% methylcellulose (MC) respectively. SE was induced in groups 6-12 by administering an aqueous (saline) solution of Li (BDH Laboratory Supplies, Poole, England in a dose as in control), followed by (20 h later) Pc (Sigma Chemical Co, St. Louis, MO, USA, in the dose as used for control). Group 6 served as the experimental control of the SE group and groups 7-12 served as the CUR (groups 7 and 8), NS (groups 9 and 10), and CIN (groups 11 and 12) test groups. CUR (Sigma, USA), was dissolved in 50% DMSO, and was administered at doses of 50 and 100 mg/kg body weight/ml orally; powdered seeds of NS (100 g), were purchased locally and were extracted in a Soxhlet extractor with ethanol (70%). The extract obtained was concentrated under reduced pressure and kept at-20 oC until being used. The NS extract was dissolved in saline and used at doses of 100 and 200 mg/kg body weight /ml orally; whereas CIN (purchased locally) was dissolved in 0.5% MC, and was administered at doses of 25 and 50 mg/kg body weight/ml orally, for seven days before the administration of Li and Pc for the induction of SE as described above. After the Pc injections, the animals (n=20 per group) were observed for a sequence of convulsive behavioral alterations, including peripheral cholinergic signs (PCS), stereotyped movements (STM), clonic movements of forelimbs, head bobbing, tremors and seizures, which developed progressively within 1-2 h into SE [44]. All seizure activities were presented as latencies to develop seizure and SE. Mortality (if any) within 24 h, was also recorded.

Cognitive Performance in Morris Water Maze

After induction of SE, the animals (n=10 to 12 per group) were subjected to cognitive behavioral studies over a period of 6 days according to the method of the Morris water-maze test [45], which has been extensively used to assess cognitive functions in a variety of epilepsy models [46,47], for visual-spatial memory performance. Animals were allowed to acclimatize to the testing room for 2 h before testing all tests were performed between 10:00 and 15:00 h of the lighted phase. The details of test are described elsewhere [2,7]. The testing procedure used during the four days of locating the hidden platform provides a measure of hippocampal-dependent spatial reference memory [48], whereas the probe trials of the water maze test (measured on the 5th day of the test for 120 s in which the platform was removed from the pool) measures the strength of spatial learning or memory recall, the closest parallel to episodic memory in humans [49].

Biochemical Studies in the Fore-Brain Tissue

Based on our pilot studies and literature survey [50-52], biochemical studies were undertaken 1 h after Li-Pc treatment.

Immediately after killing the animals (n=8 from each group) by decapitation, brains were dissected on ice. The fore-brain (which includes the hippocampus and striatum in the cerebral areas) was removed and frozen in liquid nitrogen and stored at -70°C for determination of some nonenzymatic and enzymatic oxidative stress indices.

Determination of Nonenzymatic OS Indices

Lipid Peroxides: Lipid peroxides (LP) were determined spectrophotometrically as thiobarbituric acid-reactive substances (TBARS) according to the method of Ohkawa et al. [53]. Tissue lipid peroxide levels were quantified using an extinction coefficient of 1.56×105m-1 cm-1 and expressed as nanomoles of TBARS formed per g tissue weight. The results are expressed as nmol/g wet weight.

Glutathione: Reduced glutathione (GSH) level was measured enzymatically in the brain tissues by a slightly modified method of Mangino et al. [54]. The slope of the change in absorbance was used to quantify total GSH by comparing the slope of the samples with a standard curve prepared with pure glutathione (Sigma). The specific activity is expressed into umol/g tissue weight.

Determination of Enzymatic OS Indices

Glutathione-S-Transferase: Glutathione S-transferase (GST) was estimated by the method of Habig et al. [55], by using 1-chloro-2,4-dinitrochlorobenzene (CDNB) as substrate at 340 nm. The GST activity is expressed as U/g tissue weight.

Catalase: Catalase (CAT) activity was measured by the method of Aebi [56], by tracking the decomposition of hydrogen peroxide by measuring the decrease in extinction of H2O2 at 240 nm. The activity of CAT is expressed as the rate constant of first- order reaction K per gram tissue weight.

Superoxide Dismutase: Superoxide dismutase (SOD) activity was estimated by the method of Misra and Fridovich [57]. Activity is expressed as the amount of enzyme that inhibits the oxidation of epinephrine by 50% which is equal to U per gram tissue weight.

Statistical Analysis

The data were analyzed by Bartlett’s test for equal variance and by Gaussian-shaped distribution for normality using the Kolmogorov-Smirnov goodness-of-fit test. As the data passed the normality test (????>0.10), group means were compared with one-way ANOVA with post hoc testing using Tukey-Kramer Multiple Comparisons Test or Student-Newman-Keuls Multiple Comparisons Tests. Differences in seizure and SE incidences and mortality were tested by Student-Newman-Keuls Multiple Comparisons Tests. All results were expressed as means ± SEM and the significance were defined as ????<0.05 for all tests.

RESULTS

Behavioral features of Li-Pc induced SE

After injection of Pc, all animals started developing a gradual and significant change in behavior within 5 min. Changes in behavioral features included PCS (miosis, piloerection, diarrhea, mild tremors, scratching, and salivation) and STM (sniffing, paw licking, and rearing). Seizures in 100% of animals (mean latency to develop seizures was 9.62 ± 1.2 min) were developed following the behavioral changes [Table 1]. The convulsions in the animals consisted of head bobbing with intermittent clonus of forelimbs and hind limbs, hyperextension of tails, loss of posture, falling back, and myoclonic jerks building up to SE in 100% of tested animals. The mean latency to onset of SE was 23.86 ± 1.54 min [Table 1], and on average, the SE lasted for more than one hour. Mortality of 10% was observed within 24 h following Pc injections [Table 1].

Effect of CUR, NS, and CIN pretreatment on Li-Pc induced SE

Pretreatment of animals with CUR, NS, and CIN increased the latencies to seizure and SE and decreased the percentages of seizures and SE significantly in a dose-dependent manner [Table 1]. Furthermore, it also reduced the intensity and frequency of seizure, PCS, and STM episodes [not shown in Table 1]. The three natural food compounds were effective in the order NS<CIN<CUR. The higher dose (100mg/kg) of CUR completely abolished SE [Table 1]. No mortality was observed in the rats pretreated with all three natural food products, as compared to 10% mortality in the Li-Pc treated (SE) group [Table 1]. The control groups that received saline, Li, DMSO, and MC alone did not show any signs of seizure or SE.

Morris Water-Maze Test

Animals treated with Li-Pc only (SE group) exhibited longer escape latencies to reach the platform as compared to the control group [????<0.01; Figure 1]. However, all groups developed a gradual improvement in such performance over the 4 days of testing (training) period. The number of successful animals to reach the platform was significantly higher in the CUR, NS, and CIN pretreated groups as compared to Li-Pc (SE) group on all the four testing days and the effectiveness was in the order NS<CIN<CUR [???? < 0.001; Figure 1]. The probe trial studies showed that CUR, NS, and CIN pretreated animals spent more time in the target (platform) quadrant as compared to the Li-Pc only (SE) group and the effectiveness was in the order NS<CIN<CUR [p<0.001; Figure 2].

Biochemical Studies

Nonenzymatic OS Indices in the Fore-Brain

TBARS: The lipid peroxidation level (TBARS) in the forebrain was markedly (????<0.001) increased after 1h of Li-PC (SE) treatment as compared to the control group [Figure 3A]. Pretreatment with natural compounds significantly (????<0.001) and dose-dependently attenuated Li-Pc induced an increase in TBARS in the order NS<CIN<CUR [Figure 3a], as compared to Li- Pc (SE) group.

GSH: A highly significant (????<0.001) depletion of GSH was observed in the fore-brain tissue of the Li-Pc (SE) group [Figure 3B]. Pretreatment with natural compounds significantly and dose--dependently attenuated this depletion of GSH in the order NS<CIN<CUR [Figure 3B], as compared to the Li-Pc (SE) group.

Enzymatic OS Indices in the Fore-Brain

GST: A highly significant (????<0.001) depletion of GST was observed in the Li-Pc (SE) group [Figure 4A]. Pretreatment with the natural products significantly and dose-dependently attenuated this depletion of GST in the order NS<CIN<CUR [Figure 4A], as compared to the Li-Pc (SE) group.

CAT: The CAT level in the fore-brain was markedly (????<0.001) increased after 1h of Li-PC (SE) treatment as compared to the control group [Figure 4B]. Pretreatment with natural compounds significantly (????<0.001) and dose-dependently attenuated Li-Pc induced an increase in CAT in the order NS.

SOD: The SOD level was significantly (????<0.001) decrea after 1 h of Li-PC (SE) treatment as compared to the control group [Figure 4C]. Pretreatment with natural food compounds significantly (????<0.001) and dose-dependently attenuat induced a decrease in SOD in the order NS.

DISCUSSION

The present experimental findings demonstrate that Pc administration in the pretreated rats with Li causes cholinergic symptoms followed by seizures. Within 20 to 30 minutes after Pc administration, SE developed in the rats exhibiting continuous head bobbing, intermittent forelimb and hind limb clonus, hyperextension of the tail and hind limb along with loss of posture resulting in falls (fall back from the rearing postures).

Impaired visual-spatial memory and cognitive deficit were observed in the SE-induced animals when tested in the Morris water-maze test [45]. SE-induced rats took a longer time to reach the escape platform or completely failed to reach the platform and spent less time in the target quadrant as reported earlier [2,58]. The specific cause of cognitive dysfunction following SE is far from clear. However, reports suggest that neurochemical imbalance and alterations in neuronal structure in the forebrain region following SE are possibly responsible for neurobehavioral changes [2,47,51,59,60]. The biochemical results in the present study further indicate a significant disruption in the levels of oxidative indices (enzymatic as well as non-enzymatic) in the forebrain of the rats treated with the Li-Pc suggesting for a preliminary and significant level of oxidative stress. It has been reported that over activation of excitatory amino acid receptors is an important pathogenic factor that has been implicated in the mechanisms of excitotoxicity-induced neurodegeneration leading to seizures and increased oxidative stress [61], and furthermore, neuronal loss and mossy fiber sprouting in the forebrain following SE has been attributed to the excessive production of reactive oxygen species [2,62].

Use of antioxidants could be a potential approach to arresting the seizure genesis caused by excitotoxic agents [63]. Potent antioxidant activities have been reported for CUR [5,6,8,9,21], NS [29,30], as well as CIN [32]. Although CUR and NS have been reported for having a neuroprotective role in the SE-induced models, to the author’s best knowledge, no precedent has been reported for CIN. Only during the past decade, have scientists devoted to exploring the neuroprotective/neurodegenerative aspects of cinnamon, and it was shown that multidisciplinary mechanisms are involved in this regard [35,42,43]. In the SE groups of the present study, a significant disruption in levels of oxidative stress indices in the forebrain was observed. Pretreatment with CUR, NS, and CIN significantly and dose- dependently attenuated Li-Pc-induced OS-related indices (enzymatic as well as non-enzymatic) in the forebrain region as compared to the SE group. The food products tested herein were effective in the order NS < CIN < CUR. Earlier studies have also reported that Li-Pc disrupts the OS-related indices in brain regions [2,3,64]. Thus, it is likely that similar pathomechanism might be contributing at least in part to the pathophysiology of the seizure activity herein.

CONCLUSION

The present study suggests at a preliminary level that the natural food products CUR, NS, and CIN have promising anticonvulsant and antioxidant activity against SE in rats in the order NS<CIN<CUR. However, further studies on these lines might be encouraging in developing neurotherapeutic interest in these natural food products for neurodegenerative disorders.

ACKNOWLEDGMENTS

The authors are thankful to the Deanship of Scientific Research, College of Nursing, Research Centre at King Saud University for supporting this research.

REFERENCES
  1. Chen S, Fujita S, Koshikawa N, Kobayashi M. Pilocarpine induced status epilepticus causes acute interneuron loss and hyperexcitatory propagation in rat insular cortex. Neuroscience. 2010; 66: 341-353.
  2. Tariq M, Ahmad M, Moutaery KA, Deeb SA. Pentoxifylline ameliorates lithium–pilocarpine induced status epilepticus in young rats. Epilepsy Behav. 2008; 12: 354-365.
  3. Freitas RM, Vasconcelos SMM, Souza FCF, Viana GSB, Fonteles MMF. Oxidative stress in the hippocampus after pilocarpine-induced status epilepticus in Wistar rats. FEBS J. 2005; 72: 1307-1312.
  4. Freitas RM. Investigation of oxidative stress involvement in hippocampus in epilepsy model induced by pilocarpine. Neurosci Lett. 2009; 462: 225-229.
  5. Aboul Ezz HS, Khadrawy YA, Noor NA. The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate. Neurochem Res. 2011; 36, 2195-2204.
  6. Du P, Tang HY, Li X, Lin HJ, Peng WF, Ma Y, et al. Anticonvulsive and antioxidant effects of curcumin on pilocarpine-induced seizures in rats. Chin Med J. 2012; 125: 1975-1979.
  7. Ahmad M. Protective effects of curcumin against lithium–pilocarpine induced status epilepticus, cognitive dysfunction and oxidative stress in young rats. Saudi J Biol Sci. 2013; 20: 155-162.
  8. Reeta KH, Mehla J, Pahuja M, Gupta YK. Pharmacokinetic and pharmacodynamic interaction of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Pharmacol. Biochem Behav. 2011; 99: 399- 407.
  9. Ataie A, Sabetkasaei M, Haghparast A, Moghaddam AH, Kazeminejad B. Neuroprotective effects of the polyphenolic antioxidant agent, curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rats. Pharmacol Biochem Behav. 2010; 96: 378-385.
  10. Dube C, Boyet S, Marescaux C, Nehlig A. Relationship between neuronal loss and interictal glucose metabolism during the chronic phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat. Exp Neurol. 2001; 167: 227-241.
  11. Gupta YK, Briyal S. Protective effect of vineatrol against kainic acid induced seizures, oxidative stress and on the expression of heat shock proteins in rats. Eur Neuropsychopharmacol. 2006; 16: 85-91.
  12. Freitas RL, Santos IM, De Souza GF, Tome Ada R, Saldanha GB, Freitas RM. Oxidative stress in rat hippocampus caused by pilocarpine- induced seizures is reversed by buspirone. Brain Res Bull. 2010; 81: 505-509.
  13. Choudhary KM, Mishra A, Poroikov VV, Goel RK. Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. Eur J Pharmacol. 2013; 704: 33-40.
  14. Farimah B, Majid K, Mahmood H. Neuropharmacological effects of Nigella sativa. Avicenna J Phytomed. 2016; 6: 104-116.
  15. Adami R, Bottai D. Curcumin and neurological diseases. Nutr Neurosci. 20202; 25: 441-461.
  16. Kuhad A, Pilkhwal S, Sharma S, Tirkey N, Chopra K. Effect of curcumin on inflammation and oxidative stress in displatin-induced experimental nephrotoxicity. J Agric Food Chem. 2007; 55: 10150-10155.
  17. Kalpana C, Sudheer AR, Rajasekharan KN, Menon VP. Comparative effect of curcumin and its synthetic analogue lipid peroxidation on tissue and antioxidant status during nicotine induced toxicity. Singapore Med J. 2007; 48: 124-130.
  18. Shehzad A, Ha T, Subhan F, Lee YS. New mechanisms and the anti- inflammatory role of curcumin in obesity and obesity related metabolic diseases. Eur J Nutr. 2011; 50: 151-161.
  19. Ciftci O, Aydin M, Ozdemir I, Vardi N. Quercetin prevents 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced testicular damage in rats. Andrologia. 2012; 44: 164-173.
  20. Ciftci O, Ozdemir I, Aydin M, Beytur A. Beneficial effects of chrysin on the reproductive system of adult male rats. Andrologia. 2012; 44: 181-186.
  21. Noor NA, Aboul Ezz HS, Faraag AR, Khadrawy YA. Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Epilepsy Behav. 2012; 24: 199-206.
  22. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003; 17: 299-305.
  23. Mahmood MS, Gilani AH, Khwaja A, Rashid A, Ashfaq MK. The in vitro effect of aqueous extract of Nigella sativa seeds on nitric oxide production. Phytother Res. 2003; 17: 921-924.
  24. Winkler C, Schroecksnadel K, Ledochowski M, Schennach H, Houcher B, Fuchs D. In vitro effects of Nigella sativa seeds extract on stimulated peripheral blood mononuclear cells. Pteridines. 2008; 19: 101-106.
  25. Hosseini M, Zakeri S, Khoshdast S, Yousefian FT, Rastegar M, Vafaee F, et al. The effects of Nigella sativa hydroalcoholic extract and thymoquinone on lipopolysaccharide e induced depression like behavior in rats. J Pharm Bioallied Sci. 2012; 4: 219-225.
  26. Ismail M, Al-Naqeep G, Chan KW. Nigella sativa thymoquinone- rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radic Biol Med. 2010; 48: 664-672.
  27. Sedaghat R, Roghani M, Khalili M. Neuroprotective effect of thymoquinone,  the  Nigella  sativa  bioactive  compound,  in 6-hydroxydopamine-induced hemiparkinsonian rat model. Iran J Pharm Res. 2014; 13: 227-234.
  28. Hobbenaghi R, Javanbakht J, Sadeghzadeh S, Kheradmand D, Abdi FS, Jaberi MH, et al. Neuroprotective effects of Nigella sativa extract on cell death in hippocampal neurons following experimental global cerebral ischemia-reperfusion injury in rats. J Neurol Sci. 2014; 337: 74-79.
  29. Fatemeh F, Hossein H. Protective role of Nigella sativa and Thymoquinine in oxidative stress: A review. In: Nuts and seeds in health and disease prevention. Aca Press. 2020; 127-146.
  30. Ardiana M, Pikir BS, Santoso A, Hermawan HO, Al-Farabi MJ. Effect of Nigella sativa Supplementation on Oxidative Stress and Antioxidant Parameters: A Meta-Analysis of Randomized Controlled Trials. Scient World J. 2020; 2020: 2390706.
  31. Khan A, Safdar M, Khan AMM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003; 26: 3215-3218.
  32. Dugoua JJ, Seely D, Perri D, Cooley K, Forelli T, Mills E, Koren G. From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Can J Physiol Pharmacol. 2007; 85: 837-847.
  33. Brahmachari S, Jana A, Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol. 2009; 183: 5917-5927.
  34. Ouattara B, Simard RE, Holley RA, Piette GJ, Begin A. Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms. Int J Food Microbiol. 1997; 37: 155-162.
  35. Peterson DW, George RC, Scaramozzino F, LaPointe NE, Anderson RA, Graves DJ, et al. Cinnamon extract inhibits tau aggregation associated with Alzheimer’s disease in vitro. J Alzheimers Dis. 2009; 17: 585- 597.
  36. Koppikar SJ, Choudhari AS, Suryavanshi SA, Kumari S, Chattopadhyay S, Kaul-Ghanekar R. Aqueous cinnamon extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential. BMC Cancer. 2010; 10: 210.
  37. Unlu M, Ergene E, Unlu GV, Zeytinoglu HS, Vural N. Composition, antimicrobial activity and in vitro cytotoxicity of essential oil from Cinnamomum zeylanicum Blume (Lauraceae). Food Chem Toxicol. 2010; 48: 3274-3280.
  38. Hwa JS, Jin YC, Lee,YS, Ko YS, Kim YM, Shi LY, et al. 2-Methoxy cinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1induction. J Ethnopharmacol. 2012; 139: 605-615.
  39. Kamath JV, Rana AC, Chowdhury AR. Pro-healing effect of Cinnamomum zeylanicum bark. Phytother. Res. 2003; 17: 970-972.
  40. Jayaprakasha G, Rao LJM. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum, Crit. Rev. Food Sci Nutr. 2011; 51: 547-562.
  41. Qadir MMF, Bhatti A, Ashraf MU, Sandhu MA, Anjum S, John P. Immunomodulatory and therapeutic role of Cinnamomum verum extracts in collagen-induced arthritic BALB/c mice. Inflammopharmacol. 2018; 26: 157-170.
  42. Anderson RA, Qin B, Canini F, Poulet L, Roussel AM. Cinnamon counter acts the negative effects of a high fat/high fructose diet on behavior, brain insulin signaling and Alzheimer-associated changes. PLoS One. 2013; 8: e83243.
  43. Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, et al. Orally Administrated Cinnamon Extract Reduces b-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer’s Disease Animal Models. PLoS One. 2011; 6: e16564.
  44. Persinger MA, Bureau YRJ, Kostakos M, Peredery O, Falter H. Behaviors of rats with insidious multifocal brain damage induced by seizures following single peripheral injections of lithium and pilocarpine. Physiol Behav. 1993; 53: 849-856.
  45. Morris RGM. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984; 11: 47-60.
  46. Faverjon S, Silveira DC, Fu DD, Cha,BH, Akman C, Hu Y, et al. Beneficial effects of enriched environment following status epilepticus in immature rats. Neurol. 2002; 59: 1356-1364.
  47. Rutten A, Van Albada M, Silveira DC, Cha BH, Liu X, Hu YN, et al. Memory impairment following status epilepticus in immature rats: time- course and environmental effects. Eur J Neurosci. 2002; 16: 501-513.
  48. Spiers HJ, Burgess N, Hartley T, Vargha-Khadem F, O’Keefe J. Bilateral hippocampal pathology impairs topographical band episodic memory but not visual pattern matching. Hippocampus. 2001; 11: 715-725.
  49. Jeltsch H, Bertrand F, Lazarus C, Cassel JC. Cognitive performances and locomotor activity following dentate granule cell damage in rats: role of lesion extent and type of memory tested. Neurobiol Learn Mem. 2001; 76: 81-105.
  50. Freitas RM, Vasconcelos SMM, Souza FCF, Viana GSB, Fonteles, MMF.Monoamine levels after pilocarpine induced status epilepticus in hippocampus and frontal cortex of Wistar rats. Neurosci Lett. 2004; 370: 196-200.
  51. Nascimento VS, Oliveira AA, Freitas RM, Sousa FC, Vasconcelos SMM, Viana GSB, et al. Pilocarpine-induced status epilepticus: monoamine level, muscarinic and dopaminergic receptors alterations in striatum of young rats. Neurosci Lett. 2005; 383: 165-170.
  52. Freitas RM, Oliveira AA, Vasconcelos SMM, Sousa FCF, Viana GS, Fonteles MMF. Expression of muscuranic and dopaminergic receptors and monoamine levels in frontal cortex of epileptic rats. Pharmacol Biochem Behav. 2006; 83: 302-306.
  53. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351-358.
  54. Mangino MJ, Murphy MK, Glabar GG, Anderson CB. Protective effects of glycine during hypothermic renal ischemic reperfusion injury. Am J Physiol. 1991; 261: F841-F848.
  55. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974; 249: 7130-7139.
  56. Aebi H. Methods of Enzymatic Analysis. Acad Press. 1974; 2: 673-684.
  57. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972; 247: 3170-3175.
  58. Wu CL, Huang LT, Liou CW, Wang TJ, Tung YR, Hsu HY, et al. Lithium- pilocarpine-induced status epilepticus in immature rats result in long-term deficits in spatial learning and hippocampal cell loss. Neurosci Lett. 2001; 312: 113-117.
  59. Kubova H, Mares P, Suchomelova L, Brozek G, Druga R, Pitkanen A. Status epilepticus in immature rats leads to behavioral and cognitive impairment and epileptogenesis. Eur J Neurosci. 2004; 19: 3255-3265.
  60. Morris RG, Moser EI, Riedel G, Martin SJ, Sandin J, Day M, et al. 2003. Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Philos Trans R Soc Lond B Biol Sci. 2003; 358: 773-786.
  61. Wang Q, Yu S, Simonyi A, Rottinghaus G, Sun GY, Sun AY. Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem Res. 2004; 29: 2105-2112.
  62. Ueda Y, Yokoyama H, Niwa R, Konaka R, Ohya-Nishiguchi H, Kamada H. Generation of lipid radicals in hippocampal extracellular space during kainic acid induced seizures in rats. Epilepsy Res. 1997; 26: 329-333.
  63. Schulz JB, Henshaw DR, Siwek D, Jenkins BG, Ferrante RJ, Cipolloni PB, et al. Involvement of free radicals in excitotoxicity in vivo. J Neurochem. 1995; 64: 2239-2247.
  64. Xavier SM, Barbosa CO, Barros DO, Silva RF, Oliveira AA, Freitas RM. Vitamin C antioxidant in hippocampus of adult Wistar rats after seizures and status epilepticus induced by pilocarpine. Neurosci Lett. 2007; 420: 76-79.

Ahmad M, Alharbi H, Alshehry AS, Alsadoun A (2024) Comparative Evaluation of the Ameliorating Effects of Some Natural Products as Neu rotherapeutic Interventions for a Neurodegenerative Disorder in Status Epilepticus Model. Ann Neurodegener Dis 8(1): 1035

Received : 08 Aug 2024
Accepted : 28 Aug 2024
Published : 30 Aug 2024
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X